PCSK9-IN-13

Modify Date: 2025-09-21 06:11:37

PCSK9-IN-13 structure	Common Name	PCSK9-IN-13
	CAS Number	2244129-23-3	Molecular Weight	495.62
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₀H₃₃N₅O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of PCSK9-IN-13

PCSK9-IN-13(compound 3f) is a potent PCSK9 inhibitor, which can antagonize low-density lipoprotein (LDL) receptor binding by binding to PCSK9, with an IC50 of 537 nM[1].

Name	PCSK9-IN-13

Description	PCSK9-IN-13(compound 3f) is a potent PCSK9 inhibitor, which can antagonize low-density lipoprotein (LDL) receptor binding by binding to PCSK9, with an IC50 of 537 nM[1].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Ser/Thr Protease Research Areas >> Metabolic Disease
In Vitro	PCSK9-IN-13(compound 3f) (0.1 or 1 μM) 可剂量依赖性的恢复 HepG2 肝细胞对 LDL 的摄取[1]。
In Vivo	PCSK9-IN-13(compound 3f) (3.28 or 16.4 mg/kg/day, s.c., 14 days) 在雄性 C57BL/6 小鼠中，剂量为 3.28 mg/kg 时，小鼠没有表现出总胆固醇降低，然而剂量为 16.4 mg/kg 时显示显著降低了总胆固醇血浆水平约 10%，并表现出优异的生物利用度[1]。
References	[1]. Benny J. Evison, et al. A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove.Bioorganic & Medicinal Chemistry

Molecular Formula	C₃₀H₃₃N₅O₂
Molecular Weight	495.62

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com